Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.
- DOI
- 10.1186/s12879-024-09765-4
- Published
- 2024 Sep 3
- Container
- BMC infectious diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12879-024-09765-4,
title = {Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.},
author = {Park S and Je NK and Kim DW and Park M and Heo J},
year = {2024},
journal = {BMC infectious diseases},
doi = {10.1186/s12879-024-09765-4},
url = {https://doi.org/10.1186/s12879-024-09765-4}
}RIS
TY - JOUR TI - Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study. AU - Park S AU - Je NK AU - Kim DW AU - Park M AU - Heo J PY - 2024 JO - BMC infectious diseases DO - 10.1186/s12879-024-09765-4 UR - https://doi.org/10.1186/s12879-024-09765-4 ER -
APA
S, P., NK, J., DW, K., M, P., & J, H. (2024). Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.. BMC infectious diseases. https://doi.org/10.1186/s12879-024-09765-4
Source records
- pubmed · retrieved 2026-09-25T19:57:18.888Z
- europe-pmc · retrieved 2026-09-25T19:57:18.899Z
- doaj · retrieved 2026-09-25T19:57:18.911Z